Apellis Pharmaceuticals Inc (OQ:APLS)

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for APLS within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 27th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 20/20 Feb 19/20 Francois Cedric Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -30,637  
Feb 20/20 Feb 19/20 Francois Cedric Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 30,637 $2.14
Feb 20/20 Feb 18/20 Francois Cedric Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -30,637  
Feb 20/20 Feb 18/20 Francois Cedric Direct Ownership Common Stock S - Open market or private sale -5,000 $40.67
Feb 20/20 Feb 18/20 Francois Cedric Direct Ownership Common Stock S - Open market or private sale -30,637 $40.66
Feb 20/20 Feb 18/20 Francois Cedric Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 30,637 $2.14
Feb 19/20 Feb 14/20 Machiels Alec Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -2,500  
Feb 19/20 Feb 14/20 Machiels Alec Direct Ownership Common Stock S - Open market or private sale -2,500 $42.35
Feb 19/20 Feb 14/20 Machiels Alec Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 2,500 $2.67
Feb 14/20 Feb 13/20 Deschatelets Pascal Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -117,205  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for APLS within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 27th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 20/20 Feb 19/20 Francois Cedric Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -30,637  
Feb 20/20 Feb 18/20 Francois Cedric Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -30,637  
Feb 20/20 Feb 19/20 Francois Cedric Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 30,637 $2.14
Feb 20/20 Feb 18/20 Francois Cedric Direct Ownership Common Stock S - Open market or private sale -5,000 $40.67
Feb 20/20 Feb 18/20 Francois Cedric Direct Ownership Common Stock S - Open market or private sale -30,637 $40.66
Feb 20/20 Feb 18/20 Francois Cedric Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 30,637 $2.14
Feb 19/20 Feb 14/20 Machiels Alec Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -2,500  
Feb 19/20 Feb 14/20 Machiels Alec Direct Ownership Common Stock S - Open market or private sale -2,500 $42.35
Feb 19/20 Feb 14/20 Machiels Alec Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 2,500 $2.67
Feb 14/20 Feb 13/20 Deschatelets Pascal Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -117,205  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $APLS

Competitors

Competitors with Recent Insider Filings
ChemoCentryx (OQ:CCXI)
Aptinyx (OQ:APTX)
Twist Bioscience (OQ:TWST)